You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Claims for Patent: 11,406,715

✉ Email this page to a colleague

Summary for Patent: 11,406,715

Title:	Methods of treating HER2-positive metastatic breast cancer
Abstract:	Methods of treating patients having HER2-positive, locally advanced or previously untreated metastatic breast cancer having received prior treatment with a taxane using an anti-HER2-maytansinoid conjugate (for example trastuzumab emtansine) are provided.
Inventor(s):	Alice Elizabeth Guardino, Meghna Samant, Alexander Strasak, Melanie Smitt, Monika Patre
Assignee:	Genentech Inc
Application Number:	US15/576,593
Patent Claims:

Details for Patent 11,406,715

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	HERCEPTIN	trastuzumab	For Injection	103792	September 25, 1998	11,406,715	2036-05-27
Genentech, Inc.	HERCEPTIN	trastuzumab	For Injection	103792	February 10, 2017	11,406,715	2036-05-27
Genentech, Inc.	KADCYLA	ado-trastuzumab emtansine	For Injection	125427	February 22, 2013	11,406,715	2036-05-27
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,406,715

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2016196373	⤷ Get Started Free
United States of America	2022354961	⤷ Get Started Free
United States of America	2019030181	⤷ Get Started Free
Slovenia	3302551	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.